Skip to main content
. 2020 Feb 28;16(1):41–48. doi: 10.17925/EE.2020.16.1.41

Table 2: Injection-site complications.

Variables Number of subjects (n/N) Frequency (%)
Painful injections 473/847 55.8
Frequency of painful injections
Always 9/473 1.9
Often* 40/473 8.5
Sometimes† 413/473 87.3
Almost never‡ 11/473 2.3
Bleeding and/or bruising 301/847 35.5
Frequency of bleeding and/or bruising
Always 3/301 1.0
Often* 10/301 3.3
Sometimes† 254/301 84.4
Almost never‡ 34/301 11.3
Insulin leakage from skin after injection 329/847 38.8
Frequency of insulin leakage
Always 2/329 0.6
Often* 9/329 2.7
Sometimes† 258/329 78.4
Almost never‡ 60/329 18.2
Dribble/leakage of insulin from the needle tip after injection 253/847 29.9
Frequency of insulin dribble/leakage
Always 4/253 1.6
Often* 36/253 14.2
Sometimes† 185/253 73.1
Almost never‡ 28/253 11.1
Lipohypertrophy 78/847 9.2
Site of lipohypertrophy
Abdomen 41/78 52.6
Arm 17/78 21.8
Thigh 18/78 23.1
Buttock 1/78 1.3
Other site(s) 1/78 1.3
Inject into the lipohypertrophy 30/78 38.5
Reason of injecting into the lipohypertrophy
It is less painful 5/30 16.7
It is convenient 4/30 13.3
Just as a habit 13/30 43.3
Cannot explain 8/30 26.7

*’Often’ refers to several times a week.

†’Sometimes’ refers to several times a month.

‡’Almost never’ refers to several times a year.10